Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We have examined the distribution of 5-HT1Aand 5-HT2Areceptor mRNAs in post-mortem human hippocampus, neocortex, raphe nuclei, cerebellum and basal ganglia using in situ hybridization histochemistry. Receptor transcripts in brains from two males and two females (mean age ± S.D. = 70 ± 4 years; post-mortem interval = 29 ± 6 h) were visualized with35S-radiolabelled synthetic oligodeoxyribonucleic acid probes. In the hippocampus, 5-HT1Areceptor mRNA was present in all fields, especially CA1. In the parahippocampal gyrus and neocortical regions 5-HT1Areceptor mRNA was enhanced in superficial and middle laminae. 5-HT1Areceptor mRNA was particularly abundant in the raphe and other serotonergic cell groups of the brainstem. The analysis of emulsion dipped sections showed 5-HT1Areceptor mRNA to be contracted in pyramidal neurons, together with the granule cells of the dentate gyrus. In neocortical areas lamina III pyramidal neurons were more heavily labelled than those in lamina V. There was no evidence of glial expression of 5-HT1Areceptor mRNA in grey matter or white matter compartments. 5-HT2Areceptor mRNA was present in all neocortical areas examined, where it was located in pyramidal neurons, of lamina V more than in those of lamina III, as well as in putative interneurons, especially within lamina IVc of the striate cortex. 5-HT2Areceptor mRNA was observed at minimal levels in the hippocampus and not in the raphe. Neither 5-HT1Anor 5-HT2Areceptor mRNA were detected in the cerebellum, substantia nigra or striatum. The ability to detect these transcripts at the regional and cellular level will help reveal important details of the 5-HT receptor system in the human brain. This includes the investigation of their putative roles in the normal chemoarchitecture and in pathophysiological brain processes. © 1995 Elsevier Science B.V. All rights reserved.

Original publication

DOI

10.1016/0006-8993(95)00104-X

Type

Journal article

Journal

Brain Research

Publication Date

03/04/1995

Volume

676

Pages

157 - 168